Free Trial

HEALTHCARE: Merck (A1[P]/A+/NR): 2Q24 Results

HEALTHCARE

Credit neutral.

  • Small revenue beat, 1.5% ahead of consensus.
  • Operating income 3% better than expected.
  • FY24 sales guidance is upgraded marginally, with operating expenses also higher on acquisition charges, net will hit operating profit expectations by around $1.5bn or c6%.
  • Webcast 14.00 BST https://onlinexperiences.com/scripts/Server.nxp?LASCmd=AI:4;F:QS!10100&ShowUUID=0C7C351E-923B-4F59-918A-DAFBA50F983A&LangLocaleID=1033

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.